Sanofi (SNYNF) Debt to Equity (2009 - 2025)
Sanofi (SNYNF) posted Debt to Equity of $0.26 for Q4 2025, down 10.75% sequentially from $0.29 in Q2 2025, and up 26.17% YoY from $0.21 in Q4 2024.
Sanofi (SNYNF) Debt to Equity (2009 - 2025) Analysis & Trends
Sanofi (SNYNF) has 17 years of Debt to Equity data on file, last reported at $0.26 in Q4 2025.
- Quarterly Debt to Equity rose 26.17% year-over-year to $0.26 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $0.26 (up 26.17% YoY) and the FY2025 annual result came in at $0.26, up 26.17% from the prior year.
- Debt to Equity eased to $0.26 in Q4 2025 per SNYNF's latest filing, from $0.29 in the prior quarter.
- The five-year high for Debt to Equity was $0.32 in Q2 2021, with the low at $0.21 in Q4 2024.
- Average Debt to Equity over 5 years is $0.27, with a median of $0.26 recorded in 2022.
- Year-over-year, Debt to Equity fell 17.12% in 2021 and climbed 26.17% in 2025.
- Sanofi's Debt to Equity stood at $0.3 in 2021, then decreased by 13.93% to $0.25 in 2022, then decreased by 13.0% to $0.22 in 2023, then declined by 6.76% to $0.21 in 2024, then advanced by 26.17% to $0.26 in 2025.
- Business Quant data shows SNYNF's Debt to Equity at $0.26 in Q4 2025, $0.29 in Q2 2025, and $0.21 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.39 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.68 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -9.70 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.72 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.26 |
| Jun 30, 2025 | 0.29 |
| Dec 31, 2024 | 0.21 |
| Jun 30, 2024 | 0.30 |
| Dec 31, 2023 | 0.22 |
| Jun 30, 2023 | 0.26 |
| Dec 31, 2022 | 0.25 |
| Jun 30, 2022 | 0.27 |
| Dec 31, 2021 | 0.30 |
| Jun 30, 2021 | 0.32 |
| Dec 31, 2020 | 0.36 |
| Jun 30, 2020 | 0.37 |
| Dec 31, 2019 | 24.25 |
| Jun 30, 2019 | 0.45 |
| Dec 31, 2018 | 0.42 |
| Dec 31, 2017 | 0.27 |
| Jun 30, 2017 | 0.32 |
| Dec 31, 2016 | 0.32 |
| Jun 30, 2016 | 0.00 |
| Dec 31, 2015 | 0.28 |